Filter Results:
(4,961)
Show Results For
- All HBS Web
(4,961)
- People (16)
- News (1,913)
- Research (2,479)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,889)
Show Results For
- All HBS Web
(4,961)
- People (16)
- News (1,913)
- Research (2,479)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,889)
- 16 May 2017
- First Look
First Look at New Ideas and Research, May 16
health of the enterprise rather than near-term returns to its shareholders. Their model would refocus companies’ attention to innovation, strategic renewal, and investment in the future. Publisher's link:... View Details
Keywords: Re: Multiple Faculty
- 09 Nov 2009
- Research & Ideas
Come Fly with Me: A History of Airline Leadership
were able to navigate the structures of regulation during this stage. As an industry peaks and begins to decline, leaders take center stage. Leaders are change agents who see opportunities and promise where others see only defeat. That... View Details
- 01 Sep 2013
- News
Who Are We?
vertically integrated, local market. In technology, capital flows to the location where products can be produced most quickly and cheaply for the moment; our model focuses on the long-term sustainability that comes from the health of the... View Details
- 07 Apr 2015
- News
Digital Summit Explores the New Economy
- 15 Mar 2017
- News
What's Your Favorite Case to Teach?
- 20 Sep 2011
- First Look
First Look: September 20
Hospital: Cardiac Care for the Poor (B) Tarun Khanna and Tanya BijlaniHarvard Business School Supplement 712-402 Narayana Hrudayalaya (NH) has expanded into a multi-specialty health city in Bangalore and has... View Details
Keywords: Sean Silverthorne
- 20 Jan 2015
- First Look
First Look: January 20
higher charity care and medical education. After observing regulator leniency, beneficent hospitals demonstrate higher upcoding. Our results suggest that lenient enforcement assists beneficent nonprofits to... View Details
Keywords: Sean Silverthorne
- Profile
Ben Steiner
consultants involved in business-process outsourcing to India. Ben gained experience in health care and investment banking at Goldman Sachs. “My interests became focused on affecting change through... View Details
- 27 Aug 2014
- Lessons from the Classroom
Learning From Japan’s Remarkable Disaster Recovery
executives at dozens of organizations—Google and Yahoo!, health care organizations, even a knitting business in a fishing village. They've talked with public officials in Japan and the staff of the US... View Details
- 01 Jun 2020
- News
Check In
this. Our service model at Kimpton was not service per se, it was care. What does the guest on the other side of the desk need right now? How can we properly care for them? If people are traveling right now, what they’ll need more than... View Details
- 17 Aug 2015
- Research & Ideas
Who is Boss in the Sharing Economy?
negatively affecting each other's revenues—drivers poaching each other's fares, or stylists advertising against one another—then that would seem to tilt the balance in favor of the traditional business mode. "If the spillovers are negative, and the professionals only... View Details
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)
- 01 Mar 2010
- News
Noted & Quoted
“Unfortunately, the technology for growing flu viruses to make vaccines is fifty years old — it’s chicken eggs.” — HBS Professor of Management Practice and former Merck CEO Raymond Gilmartin, at a November HBS panel discussion on drug development and availability in... View Details
- January 2021 (Revised June 2021)
- Case
Hester Pharmaceuticals (A): A Pricing Dilemma
By: Dante Roscini and John Masko
In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a... View Details
Keywords: Macroeconomics; Trade; Price; Global Range; Global Strategy; Globalized Markets and Industries; Health Care and Treatment; Patents; Monopoly; Negotiation; Business and Government Relations; Risk and Uncertainty; Human Needs; Business Strategy; Commercialization; Pharmaceutical Industry; Italy
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (A): A Pricing Dilemma." Harvard Business School Case 721-001, January 2021. (Revised June 2021.)
- August 2008 (Revised May 2009)
- Background Note
Note on Generic Drugs in the European Union
By: Robert C. Pozen and Elizabeth M. Leonard
Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of the Hatch-Waxman Act in the U.S. View Details
Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Health Care and Treatment; Trademarks; Brands and Branding; Pharmaceutical Industry; European Union; United States
Pozen, Robert C., and Elizabeth M. Leonard. "Note on Generic Drugs in the European Union." Harvard Business School Background Note 309-019, August 2008. (Revised May 2009.)
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details
- 04 May 2020
- Blog Post
Crisis Leadership with Nikhil Patel: The Critical Importance of Trust
says Patel. At the same time, he crafted models “for addressing mental health issues and comorbidities” while negotiating services and soliciting potential funders for money. Finally, Patel coordinated Detroit’s Rapid Abbott COVID-19... View Details
- 29 Jul 2008
- First Look
First Look: July 29, 2008
situation facing Gary Gottlieb, president of Brigham and Women's Hospital (BWH), prior to the opening of BWH's integrated cardiovascular center. This case allows students to develop an appreciation of the strategic, financial, organizational, clinical, and physical... View Details
Keywords: Martha Lagace
- 18 Jul 2017
- First Look
First Look at New Research and Ideas, July 18, 2017
between competitors in health care markets—whether payers or providers. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=52843 May 2017 Strategic Organization Firms, Crowds, and Innovation... View Details
Keywords: Sean Silverthorne
- 04 May 2020
- Research & Ideas
Predictions, Prophets, and Restarting Your Business
awareness of cybersecurity issues. Combined with the ability to block ads, the growing costs of acquiring customers online, the experience of “Zoombombing,” and controls on consumer data by EU regulators and others, it’s unclear how much... View Details
Keywords: by Frank V. Cespedes